CID 16130680

Azt-suc-tz14004

Structural Information

Molecular Formula
C104H158N40O23S2
SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COC(=O)CCC(=O)NN[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)N[C@H]5CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6CCCN6C(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC5=O)CC7=CC=C(C=C7)O)CCCNC(=N)N)CCCCN)CCCCN)CC8=CC=C(C=C8)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)N=[N+]=[N-]
InChI
InChI=1S/C104H158N40O23S2/c1-56-52-144(104(165)138-84(56)150)81-51-72(140-142-119)79(167-81)53-166-82(148)37-36-80(147)141-139-70(24-13-44-124-102(116)117)90(156)129-68(22-11-43-123-101(114)115)88(154)133-75(50-59-26-31-60-15-2-3-16-61(60)47-59)93(159)137-77-55-169-168-54-76(94(160)126-64(83(107)149)19-8-40-120-98(108)109)136-89(155)69(23-12-45-125-103(118)164)128-86(152)67(21-10-42-122-100(112)113)131-92(158)74(49-58-29-34-63(146)35-30-58)135-96(162)78-25-14-46-143(78)97(163)71(18-5-7-39-106)132-87(153)65(17-4-6-38-105)127-85(151)66(20-9-41-121-99(110)111)130-91(157)73(134-95(77)161)48-57-27-32-62(145)33-28-57/h2-3,15-16,26-35,47,52,64-79,81,139,145-146H,4-14,17-25,36-46,48-51,53-55,105-106H2,1H3,(H2,107,149)(H,126,160)(H,127,151)(H,128,152)(H,129,156)(H,130,157)(H,131,158)(H,132,153)(H,133,154)(H,134,161)(H,135,162)(H,136,155)(H,137,159)(H,141,147)(H4,108,109,120)(H4,110,111,121)(H4,112,113,122)(H4,114,115,123)(H4,116,117,124)(H3,118,125,164)(H,138,150,165)/t64-,65-,66-,67-,68-,69-,70-,71+,72-,73-,74-,75-,76-,77-,78-,79+,81+/m0/s1
InChIKey
KJUNTFLAVPXWLS-MYMOAFPSSA-N
Compound name
[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl 4-[2-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(3R,6S,9S,12S,15R,20R,23S,26S,29S,32S)-3,6-bis(4-aminobutyl)-20-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]-9,26-bis(3-carbamimidamidopropyl)-23-[3-(carbamoylamino)propyl]-12,29-bis[(4-hydroxyphenyl)methyl]-2,5,8,11,14,22,25,28,31-nonaoxo-17,18-dithia-1,4,7,10,13,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontan-15-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]hydrazinyl]-4-oxobutanoate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2399.1865 Da
Monoisotopic Mass

-4.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2400.1938 198.5
[M+Na]+ 2422.1757 191.2
[M-H]- 2398.1792 199.1
[M+NH4]+ 2417.2203 193.8
[M+K]+ 2438.1497 193.6
[M+H-H2O]+ 2382.1838 179.5
[M+HCOO]- 2444.1847 193.9
[M+CH3COO]- 2458.2004 195.9
[M+Na-2H]- 2420.1612 240.3
[M]+ 2399.1860 167.1
[M]- 2399.1870 167.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.